Showing results (61-70 of 301) with videos related to

Sort By:
Pageof 31
PPAR Research|September 10, 2008
Potential of peroxisome proliferator-activated receptor gamma antagonist compounds as therapeutic agents for a wide range of cancer typesJack D Burton, David M Goldenberg, Rosalyn D Blumenthal
EJNMMI Research|May 9, 2013
Radiofluorination using aluminum-fluoride (Al18F)William J McBride, Robert M Sharkey, David M Goldenberg
Expert Opinion on Biological Therapy|April 6, 2016
Prospects and progress of antibody-drug conjugates in solid tumor therapiesSerengulam V Govindan, Robert M Sharkey, David M Goldenberg
Blood|February 3, 2009
A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: prospects for dual-targeted antibody/radioantibody therapyRobert M Sharkey, Oliver W Press, David M Goldenberg
Cancer Research|October 6, 2005
Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen)Rosalyn D Blumenthal, Hans J Hansen, David M Goldenberg
Cancer Research|November 25, 2003
Meeting report on the Ninth Conference on Cancer Therapy with Antibodies and ImmunoconjugatesRobert M Sharkey, Edward A Sausville, David M Goldenberg
Plos One|May 21, 2014
Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of LupusEdmund A Rossi, Chien-Hsing Chang, David M Goldenberg
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivityChien-Hsing Chang, Edmund A Rossi, David M Goldenberg
Trends in Pharmacological Sciences|June 29, 2012
Complex and defined biostructures with the dock-and-lock methodEdmund A Rossi, David M Goldenberg, Chien-Hsing Chang
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Modulation of marrow proliferation and chemosensitivity by tumor-produced cytokines from syngeneic pancreatic tumor linesRosalyn D Blumenthal, Albert Reising, Evelyn Leon, et al.
Pageof 31